Recent Comments

Comment RSS

Pancreatic Cancer News and Research RSS Feed - Pancreatic Cancer News and Research

Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.

Study reveals effectiveness of radiation therapy in achieving local control and palliation in patients with PNTs

20. November 2009 11:10
Radiation therapy is effective in achieving local control and palliation in patients with pancreatic neuroendocrine tumors (PNTs), despite such tumors being commonly considered resistant to radiation therapy, according to a largest of its kind study in the November 15 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO). [More]

Quit smoking and get Karen Sokolof Javitch's "STAR TRACKS - THE TRIBUTE ALBUM" CD for free

20. November 2009 05:40
Karen Sokolof Javitch is hoping that her new CD: STAR TRACKS - THE TRIBUTE ALBUM will encourage people to throw away their cigarettes! "It's worth a try," says Javitch, who decided to dedicate her CD to Patrick Swayze, who recently died of pancreatic cancer. "He was a 3-pack-a-day smoker, and never quit, even when he got sick." Her mother also died at age 56 (like Patrick) and she is sure cigarette smoking contributed to her death. [More]

Posted in: Device / Technology News | Medical Condition News

Tags: , , ,

New studies suggest elevated risk of gastrointestinal cancers in diabetic patients

20. November 2009 02:27
There are minimal data assessing the relationship between diabetes with gallbladder, biliary and pancreatic cancer. Recent small studies have suggested an elevated risk of pancreatic cancer only in patients with diabetes mellitus (DM). [More]

TGen Drug Development and IPC collaborate to speed up research discoveries for cancer patients

20. November 2009 01:29
TGen Drug Development (TD2) and the Institut Paoli-Calmettes (IPC) have forged a strategic alliance that will enable both to maximize their worldwide contributions in the treatment of cancer patients. [More]

Data on Synta Pharmaceuticals' STA-9090 synthetic inhibitor of Hsp90 presented

18. November 2009 08:40
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical data presented at the AACR-NCI-EORTC Conference on Molecular Targets and Cancer Therapeutics shows that STA-9090, a novel, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated strong activity in multiple tumor models. [More]

Asuragen enters into an exclusive agreement with Life Technologies

18. November 2009 04:13
Asuragen, Inc. announced today that it has entered into an exclusive agreement with Life Technologies Corporation to develop and distribute worldwide an in-vitro diagnostic test intended to aid clinicians in the monitoring and treatment of individuals afflicted with chronic myeloid leukemia (CML). [More]

Posted in: Business / Finance | Device / Technology News

Tags: , , , , , , ,

Press conference highlights emerging treatments in pancreatic cancer

18. November 2009 03:30
As part of the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Thompson will moderate a press conference on emerging treatments in pancreatic cancer on Tuesday, Nov. 17, 2009, in Room 202 of the Hynes Convention Center in Boston, Mass., from 1:00 p.m. to 2:00 p.m. ET. [More]

African-Americans more likely to die from colorectal cancer than Caucasians, says new study

13. November 2009 00:45
New research published in the November issue of the Journal of the American College of Surgeons shows that African-American patients with colorectal cancer are more likely to be diagnosed with advanced disease and are less likely to undergo surgical procedures compared with Caucasians, suggesting that improvements in screening and rates of operation may reduce differences in colorectal cancer outcomes for African-Americans. [More]

Research and Markets' Competitive Intelligence Report on TGF-R agonists and antagonists

11. November 2009 07:53
Research and Markets has announced the addition of the "Competitor Analysis: TGF-R Agonists and Antagonists" report to their offering. [More]

Report on the emerging market for cancer vaccines

11. November 2009 03:36
This brand new report published in October 2004 provides an overview of the emerging market for cancer vaccines and measures their potential impact on a number of cancer markets. [More]

Posted in: Pharmaceutical News

Tags: , , , , , , ,

BioVex completes $70M financing to complete OncoVEX Phase III study

10. November 2009 07:51
BioVex Inc, a company developing new generation biologics for the treatment and prevention of cancer and infectious disease, announced today that it has concluded a $70 million private financing, raising $30 million in addition to the $40 million announced in March. The proceeds of the financing will primarily be used to complete the ongoing Phase III pivotal study of OncoVEX (GM-CSF) for the treatment of recurrent and metastatic melanoma and to fund pre-commercialization activities. [More]

CytRx reports financial results for the three months and nine months ended September 30, 2009

9. November 2009 09:17
CytRx Corporation, a biopharmaceutical company, today reported financial results for the three months and nine months ended September 30, 2009. [More]

Congressman Fattah lends full support to The Pancreatic Cancer Research and Education Act

7. November 2009 01:36
"Pancreatic cancer is a rare and perplexing disease, yet it is the fourth leading cause of death by cancer in the United States. This year, more than 42,000 Americans will be diagnosed with the disease and more than 35,000 will die from it. That number is far too high. [More]

Posted in: Medical Condition News

Tags: , ,

NewLink Genetics announces closing of its $30M Series C financing

6. November 2009 01:12
NewLink Genetics Corporation announced today that it has closed a $30 million Series C financing to accelerate the clinical development of its therapeutic cancer products. Total cash raised in 2009 under a combination of the previously announced Series D Preferred and the remaining shares in the Series C Preferred totaled just under $20 million. [More]

Posted in: Business / Finance

Tags: , , ,

GenVec and SAIC-Frederick signs contract to develop influenza and HIV vaccines

5. November 2009 23:52
GenVec, Inc, announced today that SAIC-Frederick, Inc. has signed a contract with GenVec for the development of influenza and HIV vaccines in support of the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.